IP Library Granted Patent US 8,217,357
Granted Patent B2
US 8,217,357 · App. 12/422,806 · Granted Jul 10, 2012

Integrated breast X-ray and molecular imaging system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,217,357
App. No.
12/422,806
Granted
Jul 10, 2012
Kind
B2
Abstract

An integrated tomosynthesis/molecular breast imaging device having improved sensitivity includes tomosynthesis imaging components and molecular breast imaging components. The imaging components may be used individually or in combination to provide a system with improved sensitivity and specificity. Molecular imaging components may be smoothly advanced or withdrawn depending upon the desired imaging mode. The system supports both PET and SPECT imaging and enables SPECT collimation to be modified in accordance with image capture requirements.

Claims (34)

1. A breast imaging device comprising:

tomosynthesis imaging components for obtaining tomosynthesis images of an anatomical structure of a breast; and

molecular imaging components for obtaining molecular breast images of a physiological structure of the breast, wherein the molecular imaging components comprise a first positionable gamma camera coupled to the gantry base and positioned above the breast during molecular image capture and a second positionable gamma camera selectively disposed within the receptor housing an positioned below the breast during molecular image capture, and each of the positionable gamma cameras removed from a field of view of the anatomical structure during tomosynthesis image capture.

2. The breast imaging device of claim 1 further comprising a compression assembly mounted on a gantry base and a receptor housing coupled to the gantry base.

3. The breast imaging system of claim 2 wherein the tomosynthesis imaging components comprise: an x-ray assembly pivotably mounted on the gantry base, the x-ray assembly comprising an x-ray source mounted on an x-support arm; and a digital detector disposed within the receptor housing.

4. The breast imaging system of claim 3 wherein a target of the x-ray source is selected from a group including tungsten and rhodium.

5. The breast imaging system of claim 2 wherein the receptor housing is sized to accommodate a digital detector, a gamma camera and an anti-scatter grid.

6. The breast imaging system of claim 2 wherein the compression assembly is used for both tomosynthesis imaging and molecular imaging, and wherein the compression assembly applies a different amount of compression for tomosynthesis imaging than for molecular imaging.

7. The breast imaging system of claim 1 wherein a positioning of the positionable gamma cameras is motor controlled.

8. The breast imaging system of claim 1 wherein a positioning of the positionable gamma cameras is manually controlled.

9. The breast imaging system of claim 1 wherein at least one of the positionable gamma cameras is at least one of retractable, rotatable and pivotable.

10. The breast imaging system of claim 1 wherein at least one of the positionable gamma cameras includes a removable collimator.

11. The breast imaging system of claim 10 wherein the removable collimator is at least one of retractable from the receptor housing, removable from the receptor housing or ejectable from the receptor housing.

12. The breast imaging system of claim 10 wherein movement of the collimator is motor controlled.

13. The breast imaging system of claim 10 wherein movement of the collimator is manually controlled.

14. The breast imaging system of claim 1 wherein the molecular imaging components comprise at least two collimators.

15. The breast imaging system of claim 1 wherein the molecular imaging components include a collimator with moveable collimation.

16. The breast imaging system of claim 1 wherein at least one of the positionable gamma cameras is a Positron Emission camera.

17. The breast imaging system of claim 1 wherein at least one of the positionable gamma cameras is a Single Photon Emission camera.

18. The breast imaging system of claim 1 further comprising a display for displaying the tomosynthesis images and the molecular breast images.

19. The breast imaging system of claim 18 wherein the tomosynthesis images comprise tomosynthesis projection images (Tp) and tomosynthesis reconstructed (Tr) images, and wherein the molecular breast images (MBI) comprise at least one of MBI projection images and MBI reconstructed images, and wherein the display is adapted to display any two of the Tr, Tp, MBI projection and MBI reconstructed images in any one of a cine mode, toggle mode, thumbnail mode or side by side mode.

20. The breast imaging system of claim 1 further comprising computer aided detection (CAD) tools for identifying potential lesions in any of the tomosynthesis and molecular breast images.

21. The breast imaging system of claim 1 wherein the tomosynthesis imaging component includes a digital detector, the molecular imaging components include a gamma detector and wherein the digital detector and gamma detector differ in size.

22. The breast imaging system of claim 21 wherein the molecular imaging components include a pair of gamma detectors, and wherein at least two of the tomosynthesis detector and pair of gamma detectors differ in size.

23. A method of imaging a breast in an integrated tomosynthesis/molecular breast imaging (T/MBI) device includes the steps of:

immobilizing the breast;

performing a tomosynthesis scan of the breast;

positioning a first gamma camera to over the breast and a second gamma camera under the breast;

obtaining a molecular image of the breast using the first and second gamma cameras ; and

decompressing the breast.

24. The method of claim 23 , further including the step of varying a compression of the breast between the step of performing the tomosynthesis scan and the step of obtaining the molecular image.

25. The method of claim 23 further including the step of removing molecular imaging components from an xray field of view prior to performing the tomosynthesis scan of the breast.

26. The method of claim 23 wherein the T/MBI device includes a gantry comprised of an x-ray assembly, a gantry base and a receptor housing and wherein the step of advancing a gamma camera proximate to the compressed breast includes the step of moving a gamma camera from within the gantry base into the receptor housing.

27. The method of claim 23 wherein the T/MBI device includes a gantry comprised of an x-ray assembly, a gantry base and a receptor housing, and wherein a compression assembly including a compression paddle having a compression well is slideably mounted to the gantry base, and wherein the step of advancing a gamma camera proximate to the compressed breast includes the step of moving a gamma camera from within the gantry base into the compression well of the compression paddle.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →